General Information,Business,Industry,Employees,Founded,Contact Information,Address,Phone Number,Web Address,View Prospectus,Financial Information,Market Cap,Revenues,Net Income,IPO Profile,Symbol,Exchange,Shares (millions),Price range,Est. $ Volume,Manager / Joint Managers,CO-Managers,Expected To Trade,Status,Quiet Period Expiration Date,Lock-Up Period Expiration Date,SCOOP Rating,Rating Change
General Information,"We intend to target early stage North American or European companies in the biotechnology sector of the healthcare industry where our management has extensive investment and operational experience. Our sponsor is an affiliate of 5AM Venture Management, LLC, or 5AM, a leading venture capital firm focused on building next-generation life science companies solving important healthcare needs with cutting-edge breakthroughs in medicine and science. Founded in 2002, 5AM has invested over $1.0 billion in 85 companies across biotechnology, drug delivery technology and other life sciences sectors of the healthcare industry, with 49 active investments in its portfolio. As of August 2020, the U.S. Food and Drug Administration, or the FDA, had approved or authorized 15 products that were developed by 5AM portfolio companies, and 5AM’s portfolio companies have enrolled over 50,000 patients in more than 35 clinical trials.",BLANK CHECKS,0,2020,Contact Information,"501 Second Street Suite 350 San Francisco, California 94107",(415) 993-8570,,5:01 ACQUISITION CORP.,Financial Information,$103.6mil,$0 mil (last 12 months),$0 mil (last 12 months),IPO Profile,FVAM,NASDAQ,8.0,$10.00 - $10.00,$80.0 mil,BofA Securities,,10/14/2020,Priced,Available only to Subscribers,Available only to Subscribers,Available only to Subscribers,Available only to Subscribers
